We addressed these limitations and knowledge gap by designing a frontal lobe-based CCT, applying it to older adults with moderate to severe depression in an RCT, and examining changes in not only mood and cognition but also BDNF. This evidence concerns the gene BDNF and depressive symptom measurement.